Mechanism for copper-deficiency mediated neutropenia

缺铜介导的中性粒细胞减少症的机制

基本信息

  • 批准号:
    8605173
  • 负责人:
  • 金额:
    $ 23.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-01-15 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Copper (Cu) is an essential trace element for normal growth and development and for the proper differentiation and function of the innate immune system. Cu deficiency causes severe neutropenia, a depletion of the phagocytic cells that represent the first line of defense in bacterial and fungal infections, thereby rendering patients susceptible to life-threatening infectious disease. Neutropenia also occurs as a consequence of radiation therapy in cancer patients, in response to drugs such as antibiotics, sedatives and anti-inflammatory agents, and as congenital or idiopathic forms of the disease. While many of the components that carry out Cu transport, distribution and utilization are well-established, the molecular mechanisms by which mammals sense Cu deficiency, and the involvement of these mechanisms in neutrophil development, represent a critical gap in our knowledge. We have discovered that a key transcriptional repressor protein in myeloid precursor cells that is required for neutrophil development, Gfi1, is severely destabilized in response to a genetic- or dietary-imposed Cu deficiency. In this proposal we outline two specific aims that will (1) identify key molecular pathways by which Cu deficiency leads to Gfi1 degradation and neutropenia and (2) test the hypothesis that dietary manipulation of Cu levels can ameliorate neutropenia. The innovative components of this proposal include: (1) establishment of a mechanistic basis for Cu deficiency- induced neutropenia (2) the elucidation of novel molecular mechanisms for Cu regulation of innate immune cell differentiation via protein degradation and (3) ascertain the potential for remediation of neutropenia by Cu supplementation. Taken together, the studies outlined in this proposal have the potential to discover novel Cu signaling pathways that modulate the development of key innate immune cells that are the first line of defense against bacterial and fungal infection.
描述(申请人提供):铜(Cu)是正常生长发育和先天免疫系统正常分化和功能所必需的微量元素。铜缺乏会导致严重的中性粒细胞减少症,即作为细菌和真菌感染第一道防线的吞噬细胞的消耗,从而使患者易患危及生命的传染病。中性粒细胞减少症也发生在癌症患者放射治疗的结果中,作为对抗生素、镇静剂和抗炎剂等药物的反应,以及作为先天性或特发性疾病形式。虽然许多进行铜运输、分布和利用的成分已经建立,但哺乳动物感知铜缺乏的分子机制,以及这些机制在中性粒细胞发育中的参与,在我们的知识中代表了一个关键的空白。我们发现骨髓前体细胞中需要一种关键的转录抑制蛋白

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dennis J Thiele其他文献

Mechanisms for copper acquisition, distribution and regulation
铜的获取、分布和调节机制
  • DOI:
    10.1038/nchembio.72
  • 发表时间:
    2008-02-15
  • 期刊:
  • 影响因子:
    13.700
  • 作者:
    Byung-Eun Kim;Tracy Nevitt;Dennis J Thiele
  • 通讯作者:
    Dennis J Thiele

Dennis J Thiele的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dennis J Thiele', 18)}}的其他基金

2015 Cell Biology of Metals Gordon Research Conference
2015金属细胞生物学戈登研究会议
  • 批准号:
    8974528
  • 财政年份:
    2015
  • 资助金额:
    $ 23.55万
  • 项目类别:
Mechanism for copper-deficiency mediated neutropenia
缺铜介导的中性粒细胞减少症的机制
  • 批准号:
    8504553
  • 财政年份:
    2013
  • 资助金额:
    $ 23.55万
  • 项目类别:
HSF1 as a therapeutic target in neurodegenerative disease
HSF1作为神经退行性疾病的治疗靶点
  • 批准号:
    8423028
  • 财政年份:
    2010
  • 资助金额:
    $ 23.55万
  • 项目类别:
HSF1 as a therapeutic target in neurodegenerative disease
HSF1作为神经退行性疾病的治疗靶点
  • 批准号:
    8220871
  • 财政年份:
    2010
  • 资助金额:
    $ 23.55万
  • 项目类别:
HSF1 as a therapeutic target in neurodegenerative disease
HSF1作为神经退行性疾病的治疗靶点
  • 批准号:
    8019461
  • 财政年份:
    2010
  • 资助金额:
    $ 23.55万
  • 项目类别:
HSF1 as a therapeutic target in neurodegenerative disease
HSF1作为神经退行性疾病的治疗靶点
  • 批准号:
    7882166
  • 财政年份:
    2010
  • 资助金额:
    $ 23.55万
  • 项目类别:
FASEB Summer Research Conference "Trace Element Metabolism: Basic and Applied Res
FASEB 夏季研究会议“微量元素代谢:基础与应用研究
  • 批准号:
    7484010
  • 财政年份:
    2008
  • 资助金额:
    $ 23.55万
  • 项目类别:
Copper Homeostasis in Mammals
哺乳动物的铜稳态
  • 批准号:
    9317601
  • 财政年份:
    2001
  • 资助金额:
    $ 23.55万
  • 项目类别:
Copper Homeostasis in Mammals
哺乳动物的铜稳态
  • 批准号:
    8300126
  • 财政年份:
    2001
  • 资助金额:
    $ 23.55万
  • 项目类别:
Copper Homeostasis in Mammals
哺乳动物的铜稳态
  • 批准号:
    7367133
  • 财政年份:
    2001
  • 资助金额:
    $ 23.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了